{"title":"肠道微生物群饮食指数与阿尔茨海默病之间的关系:来自国家健康与营养检查调查(2004年至2018年)的横断面研究。","authors":"Jingjing Liu, Shaoqiang Huang","doi":"10.1002/dad2.70170","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Emerging evidence implicates gut microbiota (GM), shaped by diet, in Alzheimer's disease (AD) pathogenesis. However, the association between the dietary index for GM (DI-GM) and AD remains unclear.</p><p><strong>Methods: </strong>This cross-sectional study analyzed data from 28,830 adults aged ≥20 years in the 2004-2018 National Health and Nutrition Examination Survey (NHANES). The DI-GM score, derived from dietary recalls, comprised beneficial to GM score (BGMS) and unfavorable to GM score (UGMS) components. AD was identified via self-report, medications, or death certificates. Multivariable weighted logistic regression, restricted cubic spline, and subgroup analyses were performed.</p><p><strong>Results: </strong>Contrary to expectations, higher DI-GM score and UGMS were associated with increased AD prevalence (DI-GM: odds ratio [OR] = 1.24, 95% CI: 1.02 to 1.52, <i>p</i> = 0.033; UGMS: OR = 1.36, 95% CI: 1.10 to 1.69, <i>p</i> = 0.005).</p><p><strong>Discussion: </strong>The DI-GM was positively associated with AD prevalence, suggesting that imbalanced plant-based diets low in protein or key nutrients may elevate AD risk despite presumed microbiota benefits.</p><p><strong>Highlights: </strong>Higher DI-GM and UGMS were significantly associated with greater AD prevalence in US adults.Restricted cubic spline analyses showed linear and non-linear associations of DI-GM and UGMS with AD, respectively.Results challenge prior assumptions that higher DI-GM scores are uniformly linked to health benefits.Imbalanced plant-based diets low in protein or key nutrients may adversely affect cognitive aging despite presumed microbiota benefits.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 3","pages":"e70170"},"PeriodicalIF":4.4000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375974/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association between the dietary index for gut microbiota and Alzheimer's disease: A cross-sectional study from the National Health and Nutrition Examination Survey (2004 to 2018).\",\"authors\":\"Jingjing Liu, Shaoqiang Huang\",\"doi\":\"10.1002/dad2.70170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Emerging evidence implicates gut microbiota (GM), shaped by diet, in Alzheimer's disease (AD) pathogenesis. However, the association between the dietary index for GM (DI-GM) and AD remains unclear.</p><p><strong>Methods: </strong>This cross-sectional study analyzed data from 28,830 adults aged ≥20 years in the 2004-2018 National Health and Nutrition Examination Survey (NHANES). The DI-GM score, derived from dietary recalls, comprised beneficial to GM score (BGMS) and unfavorable to GM score (UGMS) components. AD was identified via self-report, medications, or death certificates. Multivariable weighted logistic regression, restricted cubic spline, and subgroup analyses were performed.</p><p><strong>Results: </strong>Contrary to expectations, higher DI-GM score and UGMS were associated with increased AD prevalence (DI-GM: odds ratio [OR] = 1.24, 95% CI: 1.02 to 1.52, <i>p</i> = 0.033; UGMS: OR = 1.36, 95% CI: 1.10 to 1.69, <i>p</i> = 0.005).</p><p><strong>Discussion: </strong>The DI-GM was positively associated with AD prevalence, suggesting that imbalanced plant-based diets low in protein or key nutrients may elevate AD risk despite presumed microbiota benefits.</p><p><strong>Highlights: </strong>Higher DI-GM and UGMS were significantly associated with greater AD prevalence in US adults.Restricted cubic spline analyses showed linear and non-linear associations of DI-GM and UGMS with AD, respectively.Results challenge prior assumptions that higher DI-GM scores are uniformly linked to health benefits.Imbalanced plant-based diets low in protein or key nutrients may adversely affect cognitive aging despite presumed microbiota benefits.</p>\",\"PeriodicalId\":53226,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring\",\"volume\":\"17 3\",\"pages\":\"e70170\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375974/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/dad2.70170\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Association between the dietary index for gut microbiota and Alzheimer's disease: A cross-sectional study from the National Health and Nutrition Examination Survey (2004 to 2018).
Introduction: Emerging evidence implicates gut microbiota (GM), shaped by diet, in Alzheimer's disease (AD) pathogenesis. However, the association between the dietary index for GM (DI-GM) and AD remains unclear.
Methods: This cross-sectional study analyzed data from 28,830 adults aged ≥20 years in the 2004-2018 National Health and Nutrition Examination Survey (NHANES). The DI-GM score, derived from dietary recalls, comprised beneficial to GM score (BGMS) and unfavorable to GM score (UGMS) components. AD was identified via self-report, medications, or death certificates. Multivariable weighted logistic regression, restricted cubic spline, and subgroup analyses were performed.
Results: Contrary to expectations, higher DI-GM score and UGMS were associated with increased AD prevalence (DI-GM: odds ratio [OR] = 1.24, 95% CI: 1.02 to 1.52, p = 0.033; UGMS: OR = 1.36, 95% CI: 1.10 to 1.69, p = 0.005).
Discussion: The DI-GM was positively associated with AD prevalence, suggesting that imbalanced plant-based diets low in protein or key nutrients may elevate AD risk despite presumed microbiota benefits.
Highlights: Higher DI-GM and UGMS were significantly associated with greater AD prevalence in US adults.Restricted cubic spline analyses showed linear and non-linear associations of DI-GM and UGMS with AD, respectively.Results challenge prior assumptions that higher DI-GM scores are uniformly linked to health benefits.Imbalanced plant-based diets low in protein or key nutrients may adversely affect cognitive aging despite presumed microbiota benefits.
期刊介绍:
Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.